AstraZeneca PLC

AstraZeneca: CHMP Recommends Lynparza And Imfinzi Combination For EU Approval In Endometrial Cancer

01 يوليو 2024 00:09:21 بحسب NASDAQ US Markets

Pharma Stock Roundup: FDA's CRL to MRK & ABBV, Phase III Study Failures for NVO, AZN

28 يونيو 2024 07:33:02 بحسب NASDAQ Stocks

AstraZeneca: Imfinzi Trial Fails To Meet Endpoint In Early-stage Non-small Cell Lung Cancer

25 يونيو 2024 00:08:02 بحسب NASDAQ US Markets

AstraZeneca: Phase III Truqap Trial Plus Chemotherapy Fails To Meet Primary Goals In Breast Cancer

18 يونيو 2024 00:15:21 بحسب NASDAQ US Markets

AstraZeneca's Calquence Combo Cuts Progression Risk By 27% In Mantle Cell Lymphoma Trial

16 يونيو 2024 09:33:03 بحسب NASDAQ US Markets

FDA Approves AstraZeneca's Farxiga For Pediatric Use In Type-2 Diabetes

12 يونيو 2024 18:53:19 بحسب NASDAQ US Markets

NetDania - New 12 months High: AstraZeneca PLC

10 يونيو 2024 00:21:31 بحسب NetDania Notify

1 Biopharma Stock Setting the New Standard in Cancer Care Drugs

07 يونيو 2024 09:13:02 بحسب NASDAQ Stocks

Summit Therapeutics, AstraZeneca And More From The Year’s Biggest Cancer Conference

05 يونيو 2024 16:29:29 بحسب Forbes - World

AstraZeneca Completes Acquisition Of Fusion Pharma

05 يونيو 2024 00:08:45 بحسب NASDAQ US Markets

CHMP Recommends Approval Of AstraZeneca's Tagrisso Combo For EGFR-Mutated Advanced Lung Cancer

03 يونيو 2024 00:15:45 بحسب NASDAQ US Markets

Amgen's Bkemv Approved As First Interchangeable Biosimilar To Soliris

30 مايو 2024 02:59:20 بحسب NASDAQ US Markets

AstraZeneca Just Massively One-Upped Pfizer. Here's What It Means for the Stock

29 مايو 2024 07:20:48 بحسب NASDAQ US Markets

AstraZeneca Plans to Rake in $80 Billion by 2030. Should You Buy the Stock?

29 مايو 2024 05:32:19 بحسب NASDAQ US Markets

AZN:Datopotamab Deruxtecan Shows Favorable Survival Results, Falls Short Of Statistical Significance

26 مايو 2024 23:59:14 بحسب NASDAQ US Markets

Pharma Stock Roundup: AZN's 2030 Sales Target, PFE's New Cost Cut Plan & More

24 مايو 2024 07:30:58 بحسب NASDAQ Stocks

AstraZeneca Targets $80 Bln Revenue By 2030, Plans To Launch 20 New Medicines

21 مايو 2024 00:02:29 بحسب NASDAQ US Markets

AstraZeneca To Build $1.5 Bln Manufacturing Facility In Singapore For Antibody Drug Conjugates

19 مايو 2024 23:42:36 بحسب NASDAQ US Markets

AstraZeneca: New Data Shows Tezspire's Role In Future COPD Treatment

19 مايو 2024 19:05:22 بحسب NASDAQ US Markets

AZN:Phase III Trial Of Sipavibart Met Main Goal In Preventing COVID-19 In Immunocompromised Patients

16 مايو 2024 00:51:29 بحسب NASDAQ US Markets